Stock data
Silence Therapeutics Plc (SLN)
Silence Therapeutics Plc (SLN) reported revenue of US$0.56M and net income of -US$88.61M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.56M | US$0.34M | -US$91.08M | -US$88.61M | — |
| 2024 | US$43.26M | US$31.45M | -US$63.32M | -US$45.31M | — |
| 2023 | US$31.64M | US$18.78M | -US$64.38M | -US$54.23M | — |
| 2022 | US$21.66M | US$8.19M | -US$61.04M | -US$50.33M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$12.27M | — |
| 2026-03-31 | US$0.42M | -US$14.96M | — |
| 2025-12-31 | US$0.03M | -US$11.77M | — |
| 2025-09-30 | US$0.16M | -US$20.96M | — |
| 2025-06-30 | US$0.22M | -US$27.35M | — |
| 2025-03-31 | US$0.14M | -US$28.53M | — |
| 2024-12-31 | US$25.30M | US$12.30M | — |
| 2024-09-30 | US$1.50M | -US$35.54M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.